Literature DB >> 18643721

Comparison of postoperative pain, convalescence, and patient satisfaction after laparoscopic and percutaneous ablation of small renal masses.

Gaurav Bandi1, Sean Hedican, Timothy Moon, Fred T Lee, Stephen Y Nakada.   

Abstract

PURPOSE: To compare the convalescence and patient satisfaction between laparoscopic and percutaneous ablation for management of small renal masses.
METHODS: We performed a telephone survey comparing convalescence and operative satisfaction of patients who underwent laparoscopic and percutaneous ablation between October 2000 and June 2006 at our institution. A retrospective chart review was performed to compare perioperative and postoperative convalescence parameters.
RESULTS: A total of 93 patients underwent ablation of 103 small renal masses at our institution. Laparoscopic cryoablation was performed in 58 patients, percutaneous cryoablation in 20, and percutaneous radiofrequency ablation in 15 patients. Mean patient age was 66 years (range 24-86 years), median ASA (American society of Anesthesiologists) score was 3, and mean body mass index (BMI) was 30 kg/mm(2). There was no significant difference in the mean age, BMI, and median ASA scores between the groups. The mean diameter of the treated mass was slightly larger in the laparoscopic ablation group (2.6 cm) compared with masses in the percutaneous cryoablation (2.2 cm, P=0.027) and percutaneous radiofrequency ablation (2.2 cm, P=0.042) groups. All procedures were performed under general anesthesia. Compared with laparoscopic cryoablation, percutaneous cryoablation was associated with fewer probes used per lesion (P<0.04), shorter mean anesthesia time (P=0.001), shorter mean hospital stay (P=0.007), early return to nonstrenuous activity (P=0.007), and shorter time to complete recovery (P = 0.05). Similarly, compared with laparoscopic cryoablation, percutaneous radiofrequency ablation was associated shorter mean anesthesia time (P<0.001), early return to nonstrenuous activity (P=0.009), early return to strenuous activity (P=0.007), early return to strenuous activity (P=0.04), and early return to work (P=0.05). There was no difference in the percent of patients who had a preablation biopsy, the median opioid analgesic requirement, and patient satisfaction measured on a 0 to 5 scale between various groups.
CONCLUSION: Our study suggests that percutaneous ablation in carefully selected patients is associated with early convalescence compared with laparoscopic ablation.

Entities:  

Mesh:

Year:  2008        PMID: 18643721     DOI: 10.1089/end.2007.0261

Source DB:  PubMed          Journal:  J Endourol        ISSN: 0892-7790            Impact factor:   2.942


  9 in total

1.  Efficacy of laparoscopic renal cryoablation as an alternative treatment for small renal mass in patients with poor operability: experience from the Korean single center.

Authors:  Young Hwii Ko; Hoon Choi; Sung Gu Kang; Hong Seok Park; Jeong Gu Lee; Je Jong Kim; Seok Ho Kang; Jun Cheon
Journal:  J Laparoendosc Adv Surg Tech A       Date:  2010-05       Impact factor: 1.878

Review 2.  Renal ablation update.

Authors:  Vishal Khiatani; Robert G Dixon
Journal:  Semin Intervent Radiol       Date:  2014-06       Impact factor: 1.513

3.  Temperature isotherms during pulmonary cryoablation and their correlation with the zone of ablation.

Authors:  J Louis Hinshaw; Fred T Lee; Paul F Laeseke; Lisa A Sampson; Christopher Brace
Journal:  J Vasc Interv Radiol       Date:  2010-08-04       Impact factor: 3.464

4.  Skin-to-tumor Distance Predicts Treatment Failure of T1A Renal Cell Carcinoma Following Percutaneous Cryoablation.

Authors:  Simone L Vernez; Zhamshid Okhunov; Kamaljot Kaler; Ramy F Youssef; Rahul Dutta; Arkadiy Palvanov; Paras Shah; Kathryn Osann; David N Siegel; Igor Lobko; Louis Kavoussi; Ralph V Clayman; Jaime Landman
Journal:  Urology       Date:  2017-06-23       Impact factor: 2.649

Review 5.  Focal therapy for kidney cancer: a systematic review.

Authors:  Alexander Kutikov; David A Kunkle; Robert G Uzzo
Journal:  Curr Opin Urol       Date:  2009-03       Impact factor: 2.309

Review 6.  Role of tumor location in selecting patients for percutaneous versus surgical cryoablation of renal masses.

Authors:  Christopher J Long; Daniel J Canter; Marc C Smaldone; Tianyu Li; Jay Simhan; Boris Rozenfeld; Ervin Teper; David Y T Chen; Richard E Greenberg; Rosalia Viterbo; Robert G Uzzo; Alexander Kutikov
Journal:  Can J Urol       Date:  2012-10       Impact factor: 1.344

7.  Kidney cancer focal cryoablation trend: does location or approach matter?

Authors:  O Rodriguez Faba; F Sanguedolce; P Grange; G Kooiman; A Bakavicius; P De la Torre; J Palou
Journal:  World J Urol       Date:  2015-10-26       Impact factor: 4.226

Review 8.  Laparoscopic cryoablation vs. percutaneous cryoablation for treatment of small renal masses: a systematic review and meta-analysis.

Authors:  Kehua Jiang; Kun Tang; Xiaolin Guo; Haoran Liu; Hongbo Chen; Zhiqiang Chen; Hua Xu; Zhangqun Ye
Journal:  Oncotarget       Date:  2017-04-18

9.  Assessing Trifecta Achievement after Percutaneous Cryoablation of Small Renal Masses: Results from a Multi-Institutional Collaboration.

Authors:  Andrea Piasentin; Francesco Claps; Tommaso Silvestri; Giacomo Rebez; Fabio Traunero; Maria Carmen Mir; Michele Rizzo; Antonio Celia; Calogero Cicero; Martina Urbani; Luca Balestreri; Lisa Pola; Fulvio Laganà; Stefano Cernic; Maria Assunta Cova; Michele Bertolotto; Carlo Trombetta; Giovanni Liguori; Nicola Pavan
Journal:  Medicina (Kaunas)       Date:  2022-08-03       Impact factor: 2.948

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.